Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gemma Biotechnology
Toronto, Ontario, Canadagemmabiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Gemma Biotechnology is a Canadian biotechnology company founded in 1996 and based in Toronto, Ontario. Spun out of the University Health Network, the company focused on discovering and developing biological response modifiers for the treatment of cancer and immune system disorders. Its lead technology was Lactation-Associated ImmunoTrophic Protein (LAIT), a 50-kDa glycoprotein identified as soluble CD14 (sCD14) purified from bovine colostrum or produced recombinantly. LAIT was developed as an immune-boosting therapeutic and nutraceutical ingredient capable of inducing B-cell growth and differentiation via Toll-like receptor 4 (TLR4) pathways. The company is currently inactive.
- Therapeutic areas
- ImmunologyInfectious DiseasesOncology
- Modalities
- Recombinant proteinBiologic
- Industry
- Biotech
02
Partnerships
University Health Network
Beyond the preview
Go deeper on Gemma Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gemma Biotechnology.